Bone Biologics Corporation is a medical device company focused on bone regeneration in spinal fusion using recombinant human protein. The company's NELL-1/DBX product is an osteostimulative recombinant protein that provides target-specific control over bone regeneration. It is developing the NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease. The company was founded in 2004 and is headquartered in Burlington, MA.
What is Bone Biologics's quote symbol?
What is the 52 week high and low for Bone Biologics (NASDAQ: BBLG)?
How much is Bone Biologics stock worth today?
How much is Bone Biologics's stock price per share?
What is Bone Biologics's Market Cap?